AKT and cancer-Is it all mTOR? Article uri icon

Overview

MeSH Major

  • Neoplasms
  • Protein Kinases
  • Proto-Oncogene Proteins c-akt

abstract

  • AKT, a key regulator of cell proliferation and survival, is commonly dysregulated in human cancers. Activated AKT kinase is oncogenic and required for tumorigenesis in PTEN-deficient animals. However, the importance of AKT in mediating transformation by other oncogenes and which of its targets are necessary for this process are poorly understood. In this issue of Cancer Cell, Skeen et al. show that AKT is required for transformation by mutant H-Ras and for experimental skin carcinogenesis. Moreover, the effects of AKT are mediated predominantly or solely via mTORC1. This suggests that AKT or mTOR inhibitors will be useful treatments for many cancers.

publication date

  • October 2006

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.ccr.2006.10.001

Additional Document Info

start page

  • 254

end page

  • 6

volume

  • 10

number

  • 4